AnnMHakeMDFAAN(She/Her)
Neurology • Indianapolis, INHeadache, Movement Disorder, Neurodegenerative, Dementia & Geriatrics
Executive Director, Eli Lilly and Company. Associate Professor of Clinical Neurology, Indiana University School of Medicine.
Dr. Hake is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Lilly Corporate Center
Indianapolis, IN 46285Phone+1 317-277-7278
Summary
- I am a board-certified Neurologist, fellowship trained in Neurodegenerative diseases. I am the physician member of the Digital Health R&D team, and the Vice Chair of the Bioethics Committee at Eli Lilly and Company. I previously was an Associate Professor of Clinical Neurology at Indiana University, where I continue to see patients twice monthly and serve on the IRB.
Education & Training
Indiana UniversityMasters Certificate, Medical Informatics, 2010 - 2011
Indiana University School of MedicineFellowship, Neurodegenerative Diseases, 1997 - 1999
Brown UniversityChief Residency, Neurology, 1992 - 1993- Brown UniversityResidency, Neurology, 1990 - 1993
Creighton University School of Medicine (Omaha)Internship, Internal Medicine, 1989 - 1990- Creighton University School of MedicineClass of 1989
Certifications & Licensure
IN State Medical License 1993 - 2025- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Comparative Research of Alzheimer's Disease Drugs Start of enrollment: 2011 Apr 01
Publications & Presentations
PubMed
- 14 citationsNail Selenium Level and Diabetes in Older People in Rural China.Li Qin Su, Yin Long Jin, Frederick W. Unverzagt, Yi Bin Cheng, Ann Marie Hake
Biomedical and Environmental Sciences. 2016-11-01 - 68 citationsAPOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba.Hugh C. Hendrie, Jill R. Murrell, Olusegun Baiyewu, Kathleen A. Lane, Christianna Purnell
International Psychogeriatrics. 2014-06-01 - 644 citationsTrial of Solanezumab for Mild Dementia Due to Alzheimer’s DiseaseLawrence S. Honig, Bruno Vellas, Michael M Woodward, Mercè Boada, Roger Bullock
The New England Journal of Medicine. 2018-01-24
Other
- Clinical features and diagnosis of dementia with Lewy bodiesHake AM, Farlow MR
http://www.uptodate.com/contents/clinical-features-and-diagnosis-of-dementia-with-lewy-bodies
UpToDate, Wolters Kluwer Health - 2013-02-06 - Epidemiology, pathology, and pathogenesis of dementia with Lewy bodiesHake AM, Farlow MR
http://www.uptodate.com/contents/epidemiology-pathology-and-pathogenesis-of-dementia-with-lewy-bodie
UpToDate, Wolters Kluwer Health - 2012-11-29 - Prognosis and treatment of dementia with Lewy bodiesHake AM, Farlow MR
http://www.uptodate.com/contents/prognosis-and-treatment-of-dementia-with-lewy-bodies
UpToDate, Wolters Kluwer Health - 2013-02-06
Industry Relationships
- Employee, Eli Lilly and Co.Full-time employeeDisclosure: Salary, stock2011 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
